Morphine inhalation - Aradigm Corporation
Latest Information Update: 31 Dec 2021
At a glance
- Originator Aradigm Corporation
- Class Morphinans; Opioid analgesics; Small molecules
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer pain; Postoperative pain
Most Recent Events
- 28 Sep 2005 This compound is still in active development
- 30 Jul 2002 Phase-II clinical trials in Cancer pain in Australia (Inhalation)
- 30 Jul 2002 Phase-II clinical trials in Postoperative pain in Australia (Inhalation)